Anti-ischemic medicament
AssigneeOrion-yhtyma Oy
InventorsHeimo O. Haikala, Juoko M. Levijoki, Reijo J. Backstrom, Pentti T. Nore, Erkki J. Honkanen
Life of this patent
Estimating the term…
Abstract
A method for preventing or treating myocardial ischemia in a mammalian organism is disclosed. The compound 4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl!hydrazono!prop anedinitrile or its enantiomer or a pharmaceutically acceptable salt there is administered to a mammalian organism in need of such prevention or treatment. The compound may be administered in its racemic form or in a form which is substantially free of the (+)-enantiomer or substantially free of the (-)-enantiomer.
Claims6
A method for treating myocardial ischemia in a mammalian organism in need of such treatment, said method comprising administering an effective amount to treat myocardial ischemia of 4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl!-hydrazono!pro panedinitrile or its enantiomer or a pharmaceutically acceptable salt thereof.
A method for preventing myocardial ischemia in a mammalian organism, said method comprising administering to a mammalian organism in need of such prevention an effective amount to prevent myocardial ischemia of 4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl) phenyl!hydrazono!propanedinitrile or its enantiomer or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.